LUM and neoplasm: Therefore, soluble lumican, secreted by tumor cells or released from degraded bone matrix, may induce the cytoskeleton rearrangement of tumor cells through binding to self-expressed integrin receptor, which increases cell mobility and enhances the tumor adhering with bone matrix.